Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
25.05
+1.47 (6.23%)
Nov 22, 2024, 4:00 PM EST - Market closed
Beam Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 1,994 | 2,159 | 2,692 | 5,327 | 4,611 | - | |
| Market Cap Growth | 4.58% | -19.78% | -49.47% | 15.54% | - | - | |
| Enterprise Value | 1,230 | 1,318 | 1,776 | 4,539 | 4,443 | - | |
| Last Close Price | 25.05 | 27.22 | 39.11 | 79.69 | 81.64 | - | |
| PS Ratio | 5.86 | 5.72 | 44.18 | 102.75 | 192105.00 | - | |
| PB Ratio | 2.51 | 2.20 | 3.67 | 6.44 | 18.78 | - | |
| P/TBV Ratio | 2.45 | 2.20 | 3.67 | 6.44 | 18.78 | - | |
| P/OCF Ratio | - | - | 119.48 | - | - | - | |
| EV/Sales Ratio | 3.52 | 3.49 | 29.15 | 87.56 | 185109.63 | - | |
| Debt / Equity Ratio | 0.20 | 0.18 | 0.25 | 0.18 | 0.44 | 0.31 | |
| Asset Turnover | 0.28 | 0.27 | 0.04 | 0.05 | 0.00 | 0.00 | |
| Quick Ratio | 5.57 | 5.79 | 4.82 | 5.93 | 2.93 | 3.15 | |
| Current Ratio | 5.69 | 5.89 | 4.89 | 5.96 | 3.01 | 3.24 | |
| Return on Equity (ROE) | -18.29% | -15.46% | -37.06% | -69.13% | -112.32% | -66.67% | |
| Return on Assets (ROA) | -9.27% | -7.87% | -15.02% | -15.41% | -27.30% | -29.07% | |
| Return on Capital (ROIC) | -11.98% | -10.66% | -22.40% | -22.36% | -34.19% | -35.29% | |
| Earnings Yield | -7.20% | -6.14% | -10.74% | -6.96% | -4.22% | - | |
| FCF Yield | -7.29% | -8.47% | -0.98% | -2.12% | -2.43% | - | |
| Buyback Yield / Dilution | -9.66% | -10.19% | -9.01% | -37.43% | -621.24% | -123.90% | |
| Total Shareholder Return | -9.66% | -10.19% | -9.01% | -37.43% | -621.24% | -123.90% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.